Advertisement

Topics

Repligen Corporation; Sartorius Stedim Biotech: Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors

11:17 EDT 4 Sep 2018 | FinanzNachrichten

Development collaboration integrates Sartorius Stedim Biotech's BIOSTAT STR bioreactors and Repligen's XCell ATF cell retention control technologyCustomers to benefit from simplified, scalable solu...

Original Article: Repligen Corporation; Sartorius Stedim Biotech: Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors

NEXT ARTICLE

More From BioPortfolio on "Repligen Corporation; Sartorius Stedim Biotech: Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...